Table 3.

Motivations identified by firm representatives

	A	B	C	D	E	F
Reputational benefit
Perception of firm by consumers	X	X	X	X
Perception of firm by potential funders				X
Relationship and trust building with potential partners and stakeholders	X	X				X
Employee recruitment, satisfaction, engagement and innovation	X	X		X	X
Ranking on Dow Jones Sustainability Index*				X	X	X
Competetive advantage
Entering new markets	X		X	X	X	X
Expanding consumer base						X
Intelligence gathering on new markets		X
Anticipated long-term financial gain	X		X	X		X
Increased cost-effectiveness of interventions and programs (in developing countries)			X
Improved efficiencies					X
Opportunity for innovation	X					X
Special access to local government officials and decision making				X
Philanthropy & health impact
Obligation as a health care company				X		X
Improved population health impact	X	X	X	X	X	X
Increasing patient access to necessary medications/health services	X	X	X	X	X	X

*and/or Access to Medicine Index, Fortune World’s Most Admired Companies.